Hope For Price Flexibility After India Pretomanid Go-Ahead

Mylan gets approval in India for pretomanid as part of a combination regimen with bedaquiline and linezolid, providing new hope to patients with drug-resistant tuberculosis. Volume changes may provide opportunities to tweak prices.  

Tuberculosis
Mylan Gets Clearance For Pretomanid In India • Source: Shutterstock

Mylan N.V. has received regulatory clearance for pretomanid in India, improving the prospects of expanded access to the new treatment for drug-resistant tuberculosis, amid disturbing signals that the world’s most deadly infection may rebound sharply while healthcare systems are currently burdened with treating COVID-19.

Pretomanid, developed by the non-profit organization TB Alliance, has been given the go-ahead by the Drugs Controller General of India...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from India

More from Focus On Asia